Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Sensitivity analyses: cross-validated discrimination of the adverse blood-biomarker profile (primary outcome unless stated) by logistic regression (LR) and LightGBM. Analysis | n | Prev. | LR AUC (95% CI) | LightGBM AUC (95% CI): ≥2 of 3 cardiometabolic markers (vitamin D excluded) | 2000 | 28.0% | 0.504 (0.475 to 0.530) | 0.522 (0.493 to 0.551)

Source: Results table. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Participants were not excluded on the basis of lipid-lowering or anti-inflammatory medication.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Needle-Free Bedside and Anthropometric Measures Show Weak Discrimination of an Adverse Blood-Biomarker Profile in Middle-Aged and Older Mexican Adults: An Internally Validated Machine-Learning Study

Study design awaiting verification · Journal of Clinical Medicine · 2026

Original publication title

Needle-Free Bedside and Anthropometric Measures Show Weak Discrimination of an Adverse Blood-Biomarker Profile in Middle-Aged and Older Mexican Adults: An Internally Validated Machine-Learning Study

Exal Garcia-Carrillo; Eduardo Guzmán-Muñoz; Felipe Montalva-Valenzuela; Antonio Castillo-Paredes; Rodrigo Villaseca-Vicuña; Yeny Concha-Cisternas; Jose Jairo Narrea Vargas; Iván Molina-Marquez; Joaquín González-Aroca; Rodrigo Yáñez-Sepúlveda

© 2026 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Background/Objectives:

Needle-free measures such as grip strength, gait speed, and anthropometry are attractive as potential substitutes for blood-based biomarkers in low-resource settings, yet whether they can predict an adverse blood-biomarker profile remains unknown. This study aimed to determine whether machine-learning algorithms can predict such a profile from a defined set of needle-free bedside and anthropometric measures in Mexican adults.

Methods:

Using the Mexican Health and Aging Study (MHAS) 2012 biomarker subsample (n = 2000; mean age 62.4 years; 59.8% women), we defined a blood-based outcome: two or more of four abnormal markers (high CRP, low HDL, high cholesterol, vitamin D deficiency). Needle-free predictors were age, sex, grip strength, gait speed, blood pressure, heart rate, pulse pressure, BMI, waist, hip, waist-to-height ratio, waist-to-hip ratio, knee height, and walking-aid use. A circularity audit confirmed zero overlap. Sixteen algorithms were compared by fivefold cross-validation. Logistic regression and LightGBM were trained on 80% of the data and evaluated on a held-out 20% test set, with bootstrap CIs, calibration, SHAP, decision-curve analysis, permutation tests of the complete pipeline, and continuous regression. Sensitivity analyses varied the outcome definition, class balancing, survey weighting, and medication-related proxies.

Results:

Cross-validated ROC AUC ranged 0.481 to 0.524. LightGBM achieved AUC 0.539 (95% CI 0.477 to 0.596), and logistic regression 0.584 (0.528 to 0.638) in the held-out set, but the median held-out AUC of logistic regression across 200 random partitions was 0.518. Permutation tests of the complete cross-validated pipelines did not separate performance from chance (p ≥ 0.38). Continuous regression yielded negative R2 values for all markers (−0.14 to −0.08). No marker, sex stratum (men AUC 0.457; women 0.54), or sensitivity analysis reached useful discrimination (all AUC ≤ 0.58), and no model showed net benefit. SHAP importance was diffuse, with grip and gait ranked below all anthropometric and vital-sign features.

Conclusions:

In this sample, the evaluated bedside and anthropometric measures carried at most weak information about the predefined blood-biomarker profile, well below the level required for clinical use. They should not replace laboratory measurement of these biomarkers when biochemical assessment is clinically indicated.

An extract from the source publication. Read it in context.

At a glance

Abstract: Background/Objectives

Needle-free measures such as grip strength, gait speed, and anthropometry are attractive as potential substitutes for blood-based biomarkers in low-resource settings, yet whether they can predict an adverse blood-biomarker profile remains unknown. This study aimed to determine whether machine-learning algorithms can predict such a profile from a defined set of needle-free bedside and anthropometric measures in Mexican adults.

Source: Background/Objectives

Abstract: Results

Cross-validated ROC AUC ranged 0.481 to 0.524. LightGBM achieved AUC 0.539 (95% CI 0.477 to 0.596), and logistic regression 0.584 (0.528 to 0.638) in the held-out set, but the median held-out AUC of logistic regression across 200 random partitions was 0.518. Permutation tests of the complete cross-validated pipelines did not separate performance from chance (p ≥ 0.38). Continuous regression yielded negative R2 values for all markers (−0.14 to −0.08). No marker, sex stratum (men AUC 0.457; women 0.54), or sensitivity analysis reached useful discrimination (all AUC ≤ 0.58), and no model showed net benefit. SHAP importance was diffuse, with grip and gait ranked below all anthropometric and vital-sign features.

Source: Results

Abstract: Conclusions

In this sample, the evaluated bedside and anthropometric measures carried at most weak information about the predefined blood-biomarker profile, well below the level required for clinical use. They should not replace laboratory measurement of these biomarkers when biochemical assessment is clinically indicated.

Source: Conclusions
Authors’ abstract

Background/Objectives:

Needle-free measures such as grip strength, gait speed, and anthropometry are attractive as potential substitutes for blood-based biomarkers in low-resource settings, yet whether they can predict an adverse blood-biomarker profile remains unknown. This study aimed to determine whether machine-learning algorithms can predict such a profile from a defined set of needle-free bedside and anthropometric measures in Mexican adults.

Methods:

Using the Mexican Health and Aging Study (MHAS) 2012 biomarker subsample (n = 2000; mean age 62.4 years; 59.8% women), we defined a blood-based outcome: two or more of four abnormal markers (high CRP, low HDL, high cholesterol, vitamin D deficiency). Needle-free predictors were age, sex, grip strength, gait speed, blood pressure, heart rate, pulse pressure, BMI, waist, hip, waist-to-height ratio, waist-to-hip ratio, knee height, and walking-aid use. A circularity audit confirmed zero overlap. Sixteen algorithms were compared by fivefold cross-validation. Logistic regression and LightGBM were trained on 80% of the data and evaluated on a held-out 20% test set, with bootstrap CIs, calibration, SHAP, decision-curve analysis, permutation tests of the complete pipeline, and continuous regression. Sensitivity analyses varied the outcome definition, class balancing, survey weighting, and medication-related proxies.

Results:

Cross-validated ROC AUC ranged 0.481 to 0.524. LightGBM achieved AUC 0.539 (95% CI 0.477 to 0.596), and logistic regression 0.584 (0.528 to 0.638) in the held-out set, but the median held-out AUC of logistic regression across 200 random partitions was 0.518. Permutation tests of the complete cross-validated pipelines did not separate performance from chance (p ≥ 0.38). Continuous regression yielded negative R2 values for all markers (−0.14 to −0.08). No marker, sex stratum (men AUC 0.457; women 0.54), or sensitivity analysis reached useful discrimination (all AUC ≤ 0.58), and no model showed net benefit. SHAP importance was diffuse, with grip and gait ranked below all anthropometric and vital-sign features.

Conclusions:

In this sample, the evaluated bedside and anthropometric measures carried at most weak information about the predefined blood-biomarker profile, well below the level required for clinical use. They should not replace laboratory measurement of these biomarkers when biochemical assessment is clinically indicated.

Publication and source details

Original title: Needle-Free Bedside and Anthropometric Measures Show Weak Discrimination of an Adverse Blood-Biomarker Profile in Middle-Aged and Older Mexican Adults: An Internally Validated Machine-Learning Study

Exal Garcia-Carrillo; Eduardo Guzmán-Muñoz; Felipe Montalva-Valenzuela; Antonio Castillo-Paredes; Rodrigo Villaseca-Vicuña; Yeny Concha-Cisternas; Jose Jairo Narrea Vargas; Iván Molina-Marquez; Joaquín González-Aroca; Rodrigo Yáñez-Sepúlveda

Journal of Clinical Medicine · 2026

* Correspondence: eduardo.guzman@cloud.uautonoma.cl (E.G.-M.); felipe.montalva@ubo.cl (F.M.-V.)© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.This research received no external funding.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:38:34.986043+00:00

DOI: 10.3390/jcm15197454 · PMC13666522